These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19066009)

  • 1. Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers.
    Schmidt AC; Flick B; Jahn E; Bramlage P
    Vasc Health Risk Manag; 2008; 4(4):909-15. PubMed ID: 19066009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N; Lim PO; MacDonald TM
    Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE; DiGennaro F; Giani JF; Dominici FP
    Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
    Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
    Ruf G; Trenk D; Jähnchen E; Roskamm H
    Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans.
    Price A; Raheja P; Wang Z; Arbique D; Adams-Huet B; Mitchell JH; Victor RG; Thomas GD; Vongpatanasin W
    Hypertension; 2013 Jun; 61(6):1263-9. PubMed ID: 23547240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol: a review.
    Cockcroft J
    Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
    Dawes M; Brett SE; Chowienczyk PJ; Mant TG; Ritter JM
    Br J Clin Pharmacol; 1999 Sep; 48(3):460-3. PubMed ID: 10510163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X.
    Kayaalti F; Kalay N; Basar E; Mavili E; Duran M; Ozdogru I; Dogan A; Inanc MT; Kaya MG; Topsakal R; Oguzhan A
    Heart Vessels; 2010 Mar; 25(2):92-6. PubMed ID: 20339969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nebivolol: a beta blocker with vasodilator properties].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
    Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
    Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
    J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
    Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.